AI+大健康盈利新样本，投入AI不到3年，这家公司凭什么年入数亿？

Core Viewpoint - Huamei Haolian, a domestic AI digital health service technology group, has completed a multi-billion RMB Series D financing round, aiming to provide comprehensive health management solutions through a B2B2C and B2B model [2][3] Business Model - The business model of Huamei Haolian is based on B2B2C and B2B, where the B-end payers include insurance companies, banks, and enterprises, while the C-end consists of the customers or employees of these B-end payers [4] - Health management services provide core value to payers by helping insurance companies acquire customers and manage health proactively, thereby reducing payout risks; for banks, quality medical resources enhance financial product differentiation; and for enterprises, offering health management services boosts employee productivity and controls commercial insurance costs [5][6] Founder Background - The founder and CEO, Xu Bingyu, has a background in the health industry and has previously worked at Disney, Bank of America Merrill Lynch, and Charles River Associates, where she observed the business model of UnitedHealth Group [7][8] Market Adaptation - Xu aims to create a "Chinese version" of UnitedHealth, but faces challenges due to the differences in the healthcare landscape between China and the U.S., particularly the concentration of medical resources in top-tier hospitals [9] Strategic Partnerships - In the initial years, Huamei Haolian established trust with hospitals and standardized cooperation mechanisms, which allowed the company to leverage top-tier hospital resources to expand its payer base [11] Strategic Choices - The company has made two strategic choices: not to engage in the sale of drugs or insurance, focusing instead on being a health technology group that provides services and innovation; and to avoid entering the insurance underwriting field, maintaining a neutral position [12] AI Integration - Huamei Haolian has invested in AI research to enhance health management products, developing core algorithms for "precise medical treatment" and "traditional Chinese medicine consultation," and has launched AI applications such as "AI General Practitioner" and "AI Health Report Interpretation" [14][15] User Experience Improvement - The company aims to improve user experience by connecting fragmented healthcare services through AI, allowing patients to engage actively in their health management and receive personalized health advice [16][17] Resource Allocation - AI changes the logic of medical resource allocation by allowing users to consult AI before seeking in-person care, thus optimizing the use of limited medical resources [18][19] Product Matrix - Huamei Haolian has developed over 150 service modules, with nearly half driven by AI, allowing payers to customize solutions based on their clients' needs [25] Market Expansion - The company has established partnerships with over 1,000 medical institutions and aims to deepen its presence in the domestic market, with projections indicating the health management service market in China will grow from 1.2 trillion RMB in 2025 to 2.5 trillion RMB by 2030 [27]